期刊文献+

阿卡波糖治疗2型糖尿病疗效观察 被引量:4

Observation of Clinical Effect on Acarbose to Treat Type 2 Diabetes
下载PDF
导出
摘要 目的观察阿卡波糖对2型糖尿病患者的疗效。方法30例血糖控制不佳的2型糖尿病患者,随机分为观察组和对照组。观察组应用阿卡波糖治疗;对照组应用二甲双胍治疗,疗程均为12周。结果2组在治疗后空腹血糖、餐后2 h血糖(P2hBG)和糖化血红蛋白(HbA1c)较前明显下降,2组间在P2hBG和HbA1c降低程度上有统计学意义(P<0.05)。结论在降低P2hBG和HbA1c程度上阿卡波糖优于二甲双胍。 Objective To observe the effect of acarbose to treat the type 2 diabetes.Methods 30 case with Type2 Diabetes were randomly divided into the obeservation group and the control group.The obeservation group took acarbose for 12 weeks,the control group took metformin hydrochloride for 12 weeks.Results The fasting blood glucose(FBG),postprandial 2h blood glucose(P2hBG) and glycosylated hemoglobin(HbA1C) in both groups after treatment were effectively reduced,the P2hBG and HbA1c between two groups were singnificant difference(P〈0.05).Conclusion Acarbose was better than metformin hydrochlorideto decrease P2hBG and HbA1c.
作者 杨鹤伶
出处 《医学综述》 2009年第20期3196-3197,共2页 Medical Recapitulate
关键词 2型糖尿病 阿卡波糖 二甲双胍 Type2 Diabetes Acarbose Metformin hydrochloride
  • 相关文献

参考文献7

二级参考文献54

  • 1征革凡,王金平,张辉,胡泽溪,刘娟,肖建中,陈仕明,曹辉碧,李光伟,胡英华,潘孝仁.拜糖平治疗非胰岛素依赖型糖尿病的临床观察[J].中华内分泌代谢杂志,1995,11(3):163-164. 被引量:43
  • 2陈家伦.新一代治疗糖尿病的药物──阿卡波糖[J].中华内分泌代谢杂志,1995,11(3):170-173. 被引量:53
  • 3侯为开,张宝珠,徐进,江蓓,石增成.拜糖平治疗NIDDM的双盲对照研究[J].中国糖尿病杂志,1996,4(1):56-59. 被引量:25
  • 4相世亭.口服降糖药-阿卡波糖[J].中国药学杂志,1998,33(4):246-246. 被引量:4
  • 5Kohnert KD, Augstein P,Heinke P,et al. Chronic hyperglycemia but Not glucose variability determines HbAl c levels in well-controlled patients with type 2 diabetes[ J ]. Diabetes Res Clin Pract, 2007,77 ( 3 ) :420 - 426. 被引量:1
  • 6Hay LC, Wilmshurst EG, Fulcher G. Unrecognized hypo-and hyperglycemia in well-conctrolled patients with type 2 diabetes mellitus: the results of continuous glucose monitoring [ J ]. Diabetes Technol Ther,2003,5 : 19 - 26. 被引量:1
  • 7Monnier L, Mas E, Ginet C, et al. Acute glucose fluctuations and chronic sustained hyperglycemia as risk factors for cardiovascular diseases in patients with type 2 diabetes [ J ]. JAMA, 2006,295 (14) : 1681 - 1687. 被引量:1
  • 8Kilpatrick ES, Righy AS, Atkin SL, et al. Al c variability and the risk of microvascular complications in type 1 diabetes : data from the Diabetes Control and Complications Trial [ J ]. Diabetes Care, 2008,31 ( 11 ) :2198 - 2202. 被引量:1
  • 9Risso A, Meruri F, Quagliaro L, et al. Intermittent high glucose en-hances apoptosis in human unbilical vein endothelial cells in culture[ J ]. Am J Physiol Endocrinol Metab, 2001,281 : E924 - E930. 被引量:1
  • 10[19]Spengler M,Hobler H,Cagatay M.Long-term tolerability of acarbose.In:Lefèbvre PJ,Standl E,editors.New aspects in diabetes.Treatment strategies with alpha-glucosidase inhibitors[J].De Gruyter,Berlin,1992,286. 被引量:1

共引文献76

同被引文献30

引证文献4

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部